0001562180-22-002665.txt : 20220316
0001562180-22-002665.hdr.sgml : 20220316
20220316111619
ACCESSION NUMBER: 0001562180-22-002665
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220314
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lai Quintin J
CENTRAL INDEX KEY: 0001744326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 22743793
MAIL ADDRESS:
STREET 1: 530 HERMAN 0. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-03-14
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001744326
Lai Quintin J
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
false
true
false
false
VP Corp Development & Strategy
Common Stock
2022-03-14
4
M
false
2440.00
94.27
A
7811.8424
D
Common Stock
2022-03-14
4
M
false
5576.00
83.47
A
13387.8424
D
Common Stock
2022-03-14
4
S
false
1271.00
367.1156
D
12116.8424
D
Common Stock
2022-03-14
4
S
false
405.00
367.9442
D
11711.8424
D
Common Stock
2022-03-14
4
S
false
1254.00
369.8575
D
10457.8424
D
Common Stock
2022-03-14
4
S
false
446.00
370.9431
D
10011.8424
D
Common Stock
2022-03-14
4
S
false
600.00
371.887
D
9411.8424
D
Common Stock
2022-03-14
4
S
false
900.00
372.924
D
8511.8424
D
Common Stock
2022-03-14
4
S
false
2940.00
374.4492
D
5571.8424
D
Common Stock
2022-03-14
4
S
false
200.00
374.92
D
5371.8424
D
Stock Options (Right to buy)
94.27
2022-03-14
4
M
false
2440.00
0.00
D
2018-02-05
2027-02-05
Common Stock
2440.00
34640.00
D
Stock Options (Right to buy)
83.47
2022-03-14
4
M
false
5576.00
0.00
D
2018-02-21
2027-02-21
Common Stock
5576.00
29064.00
D
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Ryan Metz as Agent for Quintin J. Lai
2022-03-16